arrow
N

Nadine Kutsch

University of Cologne
H指数:16
被引数:1,419

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Acute and long-term outcomes of CD20-targeting CAR T-cell therapy in relapsed or refractory B-NHL: MB-CART20.1 Lymphoma phase I trial

CD20靶向CAR T细胞疗法在复发或难治性B-NHL中的短期和长期疗效:MB-CART20.1淋巴瘤I期临床试验

2026-10-160
OA
Transition Into Clinical Routine and Survival Outcomes of BCL2-and BTK Inhibitors: An Analysis of Patient Data From the GCLLSG Registry

BCL2和BTK抑制剂的临床常规应用及生存结局:一项基于GCLLSG登记数据的患者数据分析

2026-08-010
OAAI
Prognostic Value of Inflammation-Based Scores in R/R LBCL Patients Treated with CD3xCD20 Bispecific T-Cell Engagers

炎症为基础评分在复发/难治性LBCL患者接受CD3xCD20双特异性T细胞接合物治疗中的预后价值

2025-10-240
OAAI
The role of trephine bone marrow biopsies in the era of measurable residual disease-Results from the CLL10 trial of the German CLL Study Group (GCLLSG)
2024-07-240
OAAI
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy
2023-12-204
OAAI
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial

CLDN6特异性CAR-T细胞联合扩增型RNA疫苗治疗复发或难治性实体瘤:BNT211-01期临床试验

2023-10-2370
OAAI
BNT211-01: Interim results from a repeat dose escalation study of CLDN6 CAR-T cells manufactured with an automated process ± a CLDN6-encoding CAR-T cell-amplifying RNA Vaccine (CARVac)
2023-10-010
OAAI
Potential synergy between radiotherapy and CAR T-cells-a multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapy
2023-06-0120
PRE
Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy
2023-01-019
OAAI
Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
2022-06-012
OAAI
Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
2022-04-0110
OAAI
Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG)
2020-01-2737
OAAI
Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy
LEUKEMIA
IF13.4
2019-11-147
PREAI